Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 2003;93:1142-1145
doi: 10.1161/01.RES.0000108694.68635.1C
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mendelsohn, M. E.
Right arrow Articles by Rosano, G. M.C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mendelsohn, M. E.
Right arrow Articles by Rosano, G. M.C.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*NITRIC OXIDE
Related Collections
Right arrow Cardiovascular Pharmacology
Right arrow Genetically altered mice
Right arrow Endothelium/vascular type/nitric oxide
(Circulation Research. 2003;93:1142.)
© 2003 American Heart Association, Inc.


Editorials

Hormonal Regulation of Normal Vascular Tone in Males

Michael E. Mendelsohn, Giuseppe M.C. Rosano

From the Molecular Cardiology Research Institute (M.E.M.), Tufts–New England Medical Center and Department of Medicine, Tufts University School of Medicine, Boston, Mass; Cardiovascular Research Unit (G.M.C.R.), San Raffaele–Roma, Tosinvest Sanità, Roma, Italy.

Correspondence to Michael E. Mendelsohn, MD, Molecular Cardiology Research Institute, Tufts University School of Medicine, New England Medical Center, Molecular Cardiology Research Institute, 750 Washington St, Box 80, Boston, MA 02111. E-mail mmendelsohn@tufts-nemc.org


Key Words: male animals • steroid hormone receptors • vascular estrogen receptors


An extract of the first 250 words of the full text is provided, because this article has no abstract.
 

"Shall it be male or female? say the cells, And drop the plum like fire from the flesh." —Dylan Thomas

The presence of steroid hormone receptors in the vasculature of male animals has been recognized for more than two decades,1,2 and the ability of vascular estrogen receptors (ERs) to activate gene expression in vascular smooth muscle and endothelial cells from both sexes is now well established.3 We know now that normal ER function is required for skeletal development in the human male,4 male fertility,5 and normal cardiovascular development and function in males as well as females.6–8 In men, circulating estrogen levels are quite low and substantially lower than androgen levels.

How do cardiovascular tissues in men become exposed to estrogen? Males generate estrogen by synthesizing it directly from testosterone in target tissues. The enzyme aromatase, a member of the P450 superfamily of enzymes, is responsible for the conversion of C19 androgenic steroids to the corresponding estrogens, a reaction known as aromatization, since it involves conversion of the A-ring of androgens to the corresponding phenolic A-ring characteristic of estrogens (Figure). Aromatase is widely expressed in ovary, placenta, hypothalamus, liver, muscle, adipose tissue, and of note, in vascular smooth muscle and endothelial cells.9–12 Estradiol is therefore generated directly in the male vasculature, where it can activate ERs in both the cells in which it arises and in neighboring vascular smooth muscle and endothelial cells.


Figure Removed (Available Only in the Full Text)
View larger version (12K):
[in this window]
[in a new window]
 
The enzyme aromatase, a member of the P450 superfamily of enzymes, is responsible for . . . [Full Text of this Article]




This article has been cited by other articles:


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
D. Sun, C. Yan, A. Jacobson, H. Jiang, M. A. Carroll, and A. Huang
Contribution of epoxyeicosatrienoic acids to flow-induced dilation in arteries of male ER{alpha} knockout mice: role of aromatase
Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2007; 293(3): R1239 - R1246.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
A. M. Corbacho, J. P. Eiserich, L. A. Zuniga, G. Valacchi, and A. C. Villablanca
Compromised Aortic Vasoreactivity in Male Estrogen Receptor-{alpha}-Deficient Mice during Acute Lipopolysaccharide-Induced Inflammation
Endocrinology, March 1, 2007; 148(3): 1403 - 1411.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
C. F. Deschepper and B. Llamas
Hypertensive Cardiac Remodeling in Males and Females: From the Bench to the Bedside
Hypertension, March 1, 2007; 49(3): 401 - 407.
[Full Text] [PDF]


Home page
Endocr. Rev.Home page
J. L. Turgeon, M. C. Carr, P. M. Maki, M. E. Mendelsohn, and P. M. Wise
Complex Actions of Sex Steroids in Adipose Tissue, the Cardiovascular System, and Brain: Insights from Basic Science and Clinical Studies
Endocr. Rev., October 1, 2006; 27(6): 575 - 605.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
A. M. Shearman, J. A. Cooper, P. J. Kotwinski, G. J. Miller, S. E. Humphries, K. G. Ardlie, B. Jordan, K. Irenze, K. L. Lunetta, S. C. E. Schuit, et al.
Estrogen Receptor {alpha} Gene Variation Is Associated With Risk of Myocardial Infarction in More Than Seven Thousand Men From Five Cohorts
Circ. Res., March 17, 2006; 98(5): 590 - 592.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
A. M. Shearman, J. A. Cooper, P. J. Kotwinski, S. E. Humphries, M. E. Mendelsohn, D. E. Housman, and G. J. Miller
Estrogen Receptor {alpha} Gene Variation and the Risk of Stroke
Stroke, October 1, 2005; 36(10): 2281 - 2282.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
M. E. Mendelsohn and R. H. Karas
Molecular and Cellular Basis of Cardiovascular Gender Differences
Science, June 10, 2005; 308(5728): 1583 - 1587.
[Abstract] [Full Text] [PDF]